Literature DB >> 10979980

Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity.

E Roux1, F Dumont-Girard, M Starobinski, C A Siegrist, C Helg, B Chapuis, E Roosnek.   

Abstract

To evaluate the importance of the thymus for the reconstitution of immunity in recipients of a T-cell-depleted bone marrow, we measured the appearance of CD4(+)CD45RA(+)RO(-) naive T cells (thymic rebound), restoration of the diversity of the T-cell-receptor (TCR) repertoire and the response to vaccinations with tetanus toxoid (TT). Repopulation by CD4(+)CD45RA(+)RO(-) thymic emigrants varied among patients, starting at approximately 6 months after transplantation. Young patients reconstituted swiftly, whereas in older patients, the recovery of normal numbers of naive CD4(+) T cells could take several years. Restoration of TCR diversity was correlated with the number of naive CD4(+)CD45RA(+)RO(-) T cells. Moreover, the extent of the thymic rebound correlated with the patient's capacity to respond to vaccinations. Patients without a significant thymic rebound at the moment of vaccination (CD4(+)CD45RA(+)RO(-) T cells less than 30 microL) did not respond, or responded only marginally even after 3 boosts with TT. We conclude that during the first year after transplantation, the absence of an immune response is due mainly to the loss of an adequate T-cell repertoire. Restoration of the repertoire can come only from a thymic rebound that can be monitored by measuring the increase of CD4(+)CD45RA(+)RO(-) naive T cells. This will allow postponing revaccinations to a moment when the patient will be able to respond more effectively. This may be particularly useful in the elderly patient who, owing to low thymic activity, might not yet be able to respond 1 year after transplant when revaccinations are usually scheduled.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10979980

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  73 in total

1.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Onder Alpdogan; Stephanie J Muriglan; Jeffrey M Eng; Lucy M Willis; Andrew S Greenberg; Barry J Kappel; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies.

Authors:  S Masouridi-Levrat; A Pradier; F Simonetta; L Kaiser; Y Chalandon; E Roosnek
Journal:  Bone Marrow Transplant       Date:  2015-11-09       Impact factor: 5.483

3.  Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Bilal Mohty; Michael Bel; Marija Vukicevic; Monika Nagy; Emmanuel Levrat; Sara Meier; Stephane Grillet; Christophe Combescure; Laurent Kaiser; Yves Chalandon; Jakob Passweg; Claire-Anne Siegrist; Eddy Roosnek
Journal:  Haematologica       Date:  2011-03-21       Impact factor: 9.941

4.  Immune ontogeny and engraftment receptivity in the sheep fetus.

Authors:  Jessica L Skopal-Chase; John S Pixley; Alireza Torabi; Mihai C Cenariu; Anupama Bhat; David S Thain; Nicole M Frederick; Daria M Groza; Esmail D Zanjani
Journal:  Fetal Diagn Ther       Date:  2009-02-25       Impact factor: 2.587

Review 5.  Post-transplant adoptive T-cell immunotherapy.

Authors:  Nicole A Aqui; Carl H June
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

6.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

Review 7.  Thymic T-cell development in allogeneic stem cell transplantation.

Authors:  Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2011-03-22       Impact factor: 22.113

8.  The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Authors:  Il-Kang Na; Sydney X Lu; Nury L Yim; Gabrielle L Goldberg; Jennifer Tsai; Uttam Rao; Odette M Smith; Christopher G King; David Suh; Daniel Hirschhorn-Cymerman; Lia Palomba; Olaf Penack; Amanda M Holland; Robert R Jenq; Arnab Ghosh; Hien Tran; Taha Merghoub; Chen Liu; Gregory D Sempowski; Melissa Ventevogel; Nicole Beauchemin; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

9.  Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Maxim Norkin; Bronwen E Shaw; Ruta Brazauskas; Heather R Tecca; Helen L Leather; Juan Gea-Banacloche; Rammurti T Kamble; Zachariah DeFilipp; David A Jacobsohn; Olle Ringden; Yoshihiro Inamoto; Kimberly A Kasow; David Buchbinder; Peter Shaw; Peiman Hematti; Raquel Schears; Sherif M Badawy; Hillard M Lazarus; Neel Bhatt; Biljana Horn; Saurabh Chhabra; Kristin M Page; Betty Hamilton; Gerhard C Hildebrandt; Jean A Yared; Vaibhav Agrawal; Amer M Beitinjaneh; Navneet Majhail; Tamila Kindwall-Keller; Richard F Olsson; Helene Schoemans; Robert Peter Gale; Siddhartha Ganguly; Ibrahim A Ahmed; Harry C Schouten; Jane L Liesveld; Nandita Khera; Amir Steinberg; Ami J Shah; Melhem Solh; David I Marks; Witold Rybka; Mahmoud Aljurf; Andrew C Dietz; Usama Gergis; Biju George; Sachiko Seo; Mary E D Flowers; Minoo Battiwalla; Bipin N Savani; Marcie L Riches; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2018-10-02       Impact factor: 5.742

10.  Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.

Authors:  Nuno Costa; Ana E Pires; Ana M Gabriel; Luiz F Goulart; Clara Pereira; Bárbara Leal; Ana C Queiros; Wahiba Chaara; Maria F Moraes-Fontes; Carlos Vasconcelos; Carlos Ferreira; Jorge Martins; Marina Bastos; Maria J Santos; Maria A Pereira; Berta Martins; Margarida Lima; Cristina João; Adrien Six; Jocelyne Demengeot; Constantin Fesel
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.